Hugel (XKRX:145020) Additional Paid-In Capital : ₩327,287 Mil(As of Dec. 2023)

View and export this data going back to 2015. Start your Free Trial

What is Hugel Additional Paid-In Capital?

Hugel's quarterly additional paid-in capital stayed the same from Jun. 2023 (₩327,289 Mil) to Sep. 2023 (₩327,289 Mil) and stayed the same from Sep. 2023 (₩327,289 Mil) to Dec. 2023 (₩327,287 Mil).

Hugel's annual additional paid-in capital stayed the same from Dec. 2021 (₩327,289 Mil) to Dec. 2022 (₩327,289 Mil) but then declined from Dec. 2022 (₩327,289 Mil) to Dec. 2023 (₩327,287 Mil).

Hugel Additional Paid-In Capital Historical Data

The historical data trend for Hugel's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hugel Additional Paid-In Capital Chart

Hugel Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Additional Paid-In Capital

Get a 7-Day Free Trial

331,442.54

327,196.70

327,289.04

327,286.77

Hugel Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Additional Paid-In Capital	Get a 7-Day Free Trial															327,289.04	327,289.04	327,289.04	327,289.04	327,286.77

Hugel Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital

(Issue Price

Par Value)

Shares Outstanding (Diluted Average)

Hugel Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Hugel's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Hugel (XKRX:145020) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Hugel Inc (XKRX:145020) » Definitions » Additional Paid-In Capital

Comparable Companies

Traded in Other Exchanges

N/A

Address

61-20, Sinbuk-ro, Sinbuk-eup, Chuncheon, Gangwon, KOR, 24206

Website

http://www.hugel.co.kr

Hugel Inc is a biopharmaceutical company. It is in the business of manufacturing of biopharmaceuticals. The company's primary products are Botulinum toxin, Hyaluronic acid filler, and Cosmetics. It develops and promotes its products under the brand name of Wellage. The firm has manufacturing facilities in Shinbuk and Geodu.

Hugel (XKRX:145020) Headlines

No Headlines